Eli Lilly has now submitted a new drug application (NDA) for GLP-1RA orforglipron to the FDA for use in adults with obesity.
Shares in Tokyo-listed Nxera Pharma slid 5% at market open after Boehringer walked away from the neurological assets.
Transforming US drug access and production: MFN pricing deals and historic manufacturing investments
In November 2025, US President Donald Trump announced transformative actions to lower prescription drug costs and secure the ...
J&J has received the US FDA approval for Rybrevant Faspro, a SC administered therapy to treat patients with EGFR-mutated ...
The MHRA has launched a call for evidence seeking input from healthcare providers, the public, and health experts on AI ...
FREWITT S.A. located in Fribourg, Switzerland, and DEVA HOLDING A.S., located in Istanbul, Turkey are pleased to announce DEVA’s ...
We are pleased to announce that FREWITT, based in Granges-Paccot, Switzerland, and GL Pharma, headquartered in Lannach, Austria, have ...
Cremer has announced it will be attending Packexpo in Las Vegas, US. This exhibition is one of the largest, most comprehensive packaging events in the world. It features more than 2,500 exhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results